Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m 2 , or overweight patients (BMI ≥ 28 kg/m 2 ) with associated risk factors. Treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5 % of the body weight as measured at the start of therapy.
This guideline covers managing acute and chronic pancreatitis in children, young people and adults.
Xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m 2 , or overweight patients (BMI ≥ 28 kg/m 2 ) with associated risk factors. Treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5 % of the body weight as measured at the start of therapy.
alli is indicated for weight loss in adults who are overweight (body mass index, BMI, ≥28 kg/m 2 ) and should be taken in conjunction with a mildly hypocaloric, lower-fat diet.
Obesity and the links to serious medical conditions such as diabetes and cardiovascular disease.
Pancreaticoduodenectomy (PD) remains a morbid procedure. The use of Enhanced Recovery After Surgery (ERAS) pathways has proven to reduce care time and post-operative complications after colorectal surgery.
The National Institute for Health and Care Excellence (NICE) has published draft guidelines rejecting Mysimba/Contrave (bupropion and naltrexone) from Orexigen...
ACTION (Awareness, Care, and Treatment in Obesity maNagement) examined obesity-related perceptions, attitudes, and behaviors among people with obesity (PwO), health care providers (HCPs), and employer representatives (ERs).
There's little doubt that obesity now ranks among the most serious global challenges facing health professionals. According to a recent...